Affymetrix's Stock Drops After Company Recommends Against Origin's Higher Buyout Bid
Affymetrix Inc.'s stock slumped 5.2% in active afternoon trade Monday, after the biotechnology company said it determined that the buyout bid it received last week from Origin Technologies Corp. was not superior to the deal it made with Thermo Fisher Scientific Inc. .